STP705靶向TGF-β1和COX-2对抗鳞状皮肤癌

t
tlexander
楼主 (未名空间)

Apr 14, 2021 — The STP705 drug substance is composed of two siRNA
oligonucleotides, targeting TGF-β1 and COX-2 mRNA respectively.
Experimental: Part 1: Arm B. cutaneous squamous cell carcinoma (in situ)
skin canceR